Manufacturing processes, scale-up, and production
Ionis Pharmaceuticals announced positive topline results from its pivotal Phase 1-3 study of zilganersen for Alexander disease (AxD), a rare and often fatal neurological condition.
AbbVie announced an update to its 2026 earnings guidance in an 8-K filing on April 3, 2026. The update reflects a $744 million pre-tax charge for acquired IPR&D (In-Process Research and Development) a...
Moderna, Inc. announced in an 8-K filing that the FDA issued a Refusal-to-File (RTF) letter for its Biologics License Application (BLA) for mRNA-1010, its investigational seasonal influenza vaccine.
Regeneron Pharmaceuticals announced its fourth quarter and full year 2025 financial results, showcasing revenue growth driven by Dupixent and EYLEA HD. Q4 revenues increased 3% to $3.
Merck (MRK) reported its Q4 and full-year 2025 financial results, highlighting strong performance in oncology (driven by KEYTRUDA), animal health, and increasing contributions from newer products like...
Pfizer (PFE) released its Q4 and full-year 2025 financial results, reporting full-year revenues of $62.6 billion, a 2% operational decline year-over-year, although non-COVID product revenues grew 6%.